BIOFIRE FILMARRAY Tropical Fever Panel Control Kit
BioFire Defense, LLC · Decision date Jul 17, 2026
What did the FDA decide?
FDA records K261475 as a 510(k) premarket notification, with a decision dated Jul 17, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Microbiology
- Decision date
- Jul 17, 2026
Regulatory record facts
- Identifier
- K261475
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- BioFire Defense, LLC
- Product code
- PMN
- Decision code
- SESE
- Decision date
- Jul 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays.
- Applicant
- BioFire Defense, LLC
- Product code
- PMN
- FDA device class
- 2
FDA decision timeline
K261475 received
Application receipt date recorded by FDA.
K261475 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PMN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| BioFire Defense, LLC | 510(k) clearance | Nov 4, 2026 | FDA | |
| Maine Molecular Quality Controls, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Maine Molecular Quality Controls, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
| Maine Molecular Quality Controls, Inc. | 510(k) clearance | May 19, 2026 | FDA | |
MDx-Chex for BCPK260041 | STRECK LLC | 510(k) clearance | Mar 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
BioFire Defense, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Salt Lake City, UT
Sources and methodology
- Original FDA record: K261475
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


